Logo for Neurocrine Biosciences Inc

Neurocrine Biosciences Investor Relations Material

Latest events

Logo for Neurocrine Biosciences Inc

Q4 2024

Neurocrine Biosciences
Logo for Neurocrine Biosciences

Q4 2024

6 Feb, 2025
Logo for Neurocrine Biosciences

Q3 2024

30 Oct, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from Neurocrine Biosciences Inc

Access all reports
Neurocrine Biosciences, Inc. is a specialty pharmaceutical company that has a pipeline of drugs targeting multiple diseases and disorders of the central nervous system (CNS), including movement disorders, endocrine disorders and psychiatry.